Back to Results
First PageMeta Content
Janus kinase inhibitor / Placebo / Thrombocytosis / Polycythemia vera / Splenomegaly / Leukemia / Medicine / Ruxolitinib / Myelofibrosis


ruxolitinib (as phosphate), 5mg, 15mg, & 20mg tablets (Jakavi®) SMC No[removed]Novartis Pharmaceuticals UK Ltd. 06 February 2015 The Scottish Medicines Consortium (SMC) has completed its assessment of the above produc
Add to Reading List

Open Document

File Size: 211,95 KB

Share Result on Facebook
UPDATE